Unknown membrane-associated receptors on fibroblasts, chondrocytes, and osteoblasts

This target refers to a hypothesized set of membrane-associated receptors located on fibroblasts, chondrocytes, and osteoblasts, primarily identified in the context of the drug ipriflavone. Historically, ipriflavone was described as acting through these unknown receptors to stimulate the proliferation and differentiation of bone-forming cells while inhibiting bone resorption by osteoclasts. Recent research has begun to clarify this mechanism, suggesting that the drug interacts with the Hedgehog signaling pathway, specifically inhibiting Indian Hedgehog (IHH) signaling and modulating the Smoothened (Smo)-Gli2 axis to regulate the transcription factor RUNX2. These receptors play a critical role in maintaining bone density and skeletal integrity, making them a focal point for therapies aimed at metabolic bone diseases. Despite these advancements, the precise molecular identity of the primary binding site remains partially characterized in standard pharmacological literature.

Other names

Ipriflavone targetMembrane-associated receptors on bone cellsPutative ipriflavone receptor

Stimulation of osteoblast activity and inhibition of osteoclast-mediated bone resorption, potentially via modulation of the Hedgehog signaling pathway (IHH/Smo/Gli2).